The role of Alpha1-Adrenergic Receptors Promoter Methylation in Cerebral Autoregulation in Fetus

α1-肾上腺素能受体启动子甲基化在胎儿大脑自动调节中的作用

基本信息

  • 批准号:
    10657080
  • 负责人:
  • 金额:
    $ 38.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-04-07 至 2028-02-29
  • 项目状态:
    未结题

项目摘要

Summary: The ability of an organism to reduce the brain blood flow in response to sudden surges in systemic blood pressure (BP) is known as cerebral autoregulation (CAR). In contrast to term neonates, preterm neonates are not able to reduce cerebral blood flow (CBF) in response to increased systemic BP. In preterm neonates, this exposes fragile cerebral vessels to a significantly increased blood flow at high pressure, leading to their rupture and brain damage. Our preliminary studies demonstrate that near-term fetuses can constrict carotid arteries and reduce CBF when systemic BP rises; however, this capability is not developed in the preterm fetus. We also observed that the constriction of carotid arteries to reduce CBF is regulated by the adrenergic nervous system, specifically by the activities of alpha-1 adrenergic receptors (α1-ARs). These receptors are expressed at a significantly lower number in preterm carotid arteries. Also, we observed that following the removal of adrenergic control in the near-term fetus by severing the superior cervical ganglion (SCG) made them lose their ability to reduce carotid blood flow (CaBF) to the brain with the rise in systemic BP. Thus, after the removal of SCG, both preterm and near-term fetuses cannot reduce CBF following an increase in systemic BP. During ex-vivo experiments on carotid segments, we observed that preterm arterial constriction in response to α1-ARs agonist was significantly lower than those from near-term lambs. Thus, we concluded that reduced activities of α1-ARs play a fundamental role in regulating CaBF with the rise in systemic BP. We also observed that the reduction in the activities of α1-ARs agonists in preterm resulted from reduced expression of α1-ARs compared to those in near-term fetal lambs. Furthermore, we present evidence that DNA hypermethylation reduces α1-ARs promoter activities by luciferase reporter assays and the involvement of histone modifications. Thus, we will test the hypothesis that promoter DNA hypermethylation and histone modifications reduce the expression and function of α1-AR subtypes (α1A-, α1B-, α1D) in the carotid arteries and play an essential role in the maturation of cerebral autoregulation from preterm to term fetus. We will also collect data from both sexes (male versus female) to identify sex-related changes. The studies will be conducted ex-vivo on isolated carotid arteries and in vivo in chronically catheterized fetal sheep. The hypothesis will be tested with two specific aims. Aim 1: From preterm to term fetus in a sex- specific manner, we will conduct an in-depth mechanistic analysis of promoter DNA methylation and histone modifications on differential expression of α1-AR subtypes in carotid arteries. Aim 2: From preterm to term fetus, in a sex-specific manner, we will determine the functional significance of differential α1-AR subtypes promoter methylation, histone modifications, and gene expression on carotid artery contractility and blood flow regulation to the brain in response to an increase in systemic pressure. The measurements will be conducted in real-time, in-vivo, with in-utero fetal maturation every week from 105 to 137 days. This will provide valuable information regarding the role of α1-AR subtypes and the epigenetic mechanisms involved in the maturation of CAR.
摘要:有机体能够减少脑血流而响应全身血压的突然激增的能力 (BP)被称为脑自动调节(CAR)。与术语新生儿相比,早产新生儿无法减少 响应于全身性BP的响应脑血流(CBF)。在早产新生儿中,这暴露了脆弱的脑血管 高压下的血液流量显着增加,导致其破裂和脑损伤。我们的初步研究 证明近期胎儿可以收缩颈动脉,并在全身性BP上升时减少CBF;但是,这个 早产胎儿没有发展能力。我们还观察到,颈动脉减少CBF的收缩是 受肾上腺神经系统的调节,特别是由α-1肾上腺素受体(α1-ARS)的活性调节。这些 在早产颈动脉中,受体以显着较低的数量表达。另外,我们观察到遵循 通过几个上宫颈神经节(SCG)使近期胎儿的肾上腺控制控制使他们失去了 随着全身性BP的增加,能够减少颈动脉血流(CABF)到大脑。在删除SCG之后,两者都 全身性BP增加后,早产和近期胎儿无法减少CBF。在实体实验期间 颈动脉片段,我们观察到,对α1-ARS激动剂的反应早产动脉收缩显着低于 那些来自近期羔羊。我们得出的结论是,减少的α1-AR的活动在调节中起着基本作用 CABF随着全身性BP的增加。我们还观察到早产中α1-ARS激动剂的活性的减少 与近期胎儿羔羊相比,α1-AR的表达降低。此外,我们提供证据 DNA高甲基化可通过荧光素酶报告基准测定和组蛋白参与来降低α1ARS启动子的活性 修改。这是我们将检验的假设,即启动子DNA高甲基化和Hisstone修饰降低了 颈动脉中α1-AR亚型(α1a-,α1b-,α1d)的表达和功能,在成熟中起着至关重要的作用 从早产到胎儿的脑自动调节。我们还将收集来自男女的数据(男性与女性) 确定与性别相关的变化。研究将在分离的颈动脉和体内进行长期进行的研究 导管胎羊。该假设将以两个具体目标进行检验。目标1:从早产到性别的胎儿 - 特定方式,我们将对启动子DNA甲基化和Hisstone修饰进行深入的机械分析 关于颈动脉中α1-ar亚型的差异表达。目标2:从早产到胎儿,以性别特定的方式, 我们将确定差异α1-ar亚型甲基化,Hisstone修饰的功能显着性, 以及对颈动脉收缩力和血流调节向大脑的基因表达,以响应增加 系统性压力。测量结果将在体内实时进行,每周胎儿成熟 从105到137天。这将提供有关α1-ar亚型和表观遗传的作用的宝贵信息 汽车成熟涉及的机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ravi Goyal其他文献

Ravi Goyal的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ravi Goyal', 18)}}的其他基金

Alpha Adrenergic Methylation and Developmental Maturation of Cerebral Autoregulation in Ovine Preterm Fetus
羊早产儿的α肾上腺素能甲基化和大脑自动调节的发育成熟
  • 批准号:
    10661985
  • 财政年份:
    2023
  • 资助金额:
    $ 38.38万
  • 项目类别:
Modeling and simulation tools for optimizing design of network-informed clinical trials of combination HIV prevention interventions
用于优化 HIV 预防联合干预措施的网络信息临床试验设计的建模和模拟工具
  • 批准号:
    10622168
  • 财政年份:
    2022
  • 资助金额:
    $ 38.38万
  • 项目类别:
Epigenetic Mechanisms of Developmental Regulation of Fetal, Newborn, and Adult Cerebral Artery Sympathetic Innervation and Alpha1 Adrenergic Receptor Subtypes
胎儿、新生儿和成人脑动脉交感神经支配和α1肾上腺素能受体亚型发育调节的表观遗传机制
  • 批准号:
    9237948
  • 财政年份:
    2016
  • 资助金额:
    $ 38.38万
  • 项目类别:
Mechanisms of acclimatization responses of fetal and adult cerebral artery alpha1 adrenergic receptor subtypes to long-term hypoxia
胎儿和成人脑动脉α1肾上腺素能受体亚型对长期缺氧的适应反应机制
  • 批准号:
    9072344
  • 财政年份:
    2016
  • 资助金额:
    $ 38.38万
  • 项目类别:
Cerebral Artery Alpha1 Adrenergic and PKC Regulatory Mechanisms
脑动脉 Alpha1 肾上腺素能和 PKC 调节机制
  • 批准号:
    8811457
  • 财政年份:
    2015
  • 资助金额:
    $ 38.38万
  • 项目类别:
RAF KINASE AND EPIGENETIC REGULATION OF FETAL VASCULAR DEVELOPMENT
RAF 激酶和胎儿血管发育的表观遗传调控
  • 批准号:
    9134923
  • 财政年份:
    2015
  • 资助金额:
    $ 38.38万
  • 项目类别:
Role of LincRNA in Developmental Regulation of Angiogenesis
LincRNA 在血管生成发育调控中的作用
  • 批准号:
    8768569
  • 财政年份:
    2014
  • 资助金额:
    $ 38.38万
  • 项目类别:

相似国自然基金

肾上腺素能受体激动剂引起睑板腺功能障碍发病的机制研究
  • 批准号:
    82371024
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
β2肾上腺素能受体基因多态性Arg16Gly影响慢性心衰预后及 β受体阻滞剂疗效的机制研究
  • 批准号:
    81800356
  • 批准年份:
    2018
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目
β-受体拮抗剂对曲妥珠单抗的增效作用及其机制研究
  • 批准号:
    81773258
  • 批准年份:
    2017
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
β2肾上腺素能受体激动剂通过cAMP/PKA通路调控MSCs旁分泌在急性肺损伤修复中的作用和机制
  • 批准号:
    81500058
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
选择性β1肾上腺素能受体阻断剂抗骨质疏松的作用及机理研究
  • 批准号:
    81300710
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

A role for cardiomyocyte pannexin 1 in non-ischemic heart failure
心肌细胞pannexin 1在非缺血性心力衰竭中的作用
  • 批准号:
    10680109
  • 财政年份:
    2023
  • 资助金额:
    $ 38.38万
  • 项目类别:
A full spectrum rational approach to identify antiarrhythmic agents targeting IKs Channels
识别针对 IK 通道的抗心律失常药物的全谱理性方法
  • 批准号:
    10734513
  • 财政年份:
    2023
  • 资助金额:
    $ 38.38万
  • 项目类别:
Role of novel RNA binding protein LARP6 in alcoholic cardiomyopathy
新型RNA结合蛋白LARP6在酒精性心肌病中的作用
  • 批准号:
    10593688
  • 财政年份:
    2023
  • 资助金额:
    $ 38.38万
  • 项目类别:
The role of VSNL1 in human heart rate regulation
VSNL1在人体心率调节中的作用
  • 批准号:
    10750747
  • 财政年份:
    2023
  • 资助金额:
    $ 38.38万
  • 项目类别:
Community-informed approaches to the escalating presence of xylazine in opioids
针对阿片类药物中甲苯噻嗪含量不断增加的社区知情方法
  • 批准号:
    10701304
  • 财政年份:
    2023
  • 资助金额:
    $ 38.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了